Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Standardized OTC labels could minimize line extension confusion -- APhA.

This article was originally published in The Tan Sheet

Executive Summary

STANDARDIZED OTC LABEL COULD HELP TO ELIMINATE LINE EXTENSION CONFUSION, American Pharmaceutical Association (APhA) Board of Trustees member Janet Engle maintained at a Sept. 29 FDA public hearing on OTC labeling. Consumers may "assume that a consistent brand name on an over-the-counter drug product refers to consistent active ingredients," which is not always true "given the trend toward over-the-counter brand name line extensions," Engle said.
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084384

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel